Immunotoxicity induced in mice by subacute exposure to berberine

Journal of Immunotoxicology

Volumn 13, Issue 2, 2016, Pages 255-262

  Mahmoudi, Mahmoud ^a   Zamani Taghizadeh Rabe, Shahrzad ^b   Balali Mood, Mahdi ^c   Karimi, Gholamreza ^c   Memar, Bahram ^d   Rahnama, Maryam ^b   Tabasi, Nafiseh ^b   Khazaee, Mahdieh ^b   Riahi Zanjani, Bamdad ^c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Berberine; cellular immunity; humoral immunity; immunotoxicity

Indexed keywords

BERBERINE; CYCLOPHOSPHAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; DRUG MEGADOSE; HEMAGGLUTINATION; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNOMODULATION; IMMUNOTOXICITY; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SPLEEN WEIGHT; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; IMMUNOLOGY; PATHOLOGY; SPLEEN;

ANIMALS; BERBERINE; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERSENSITIVITY, DELAYED; IMMUNITY, HUMORAL; MALE; MICE; MICE, INBRED BALB C; SPLEEN;

EID: 84953307519     PISSN: 1547691X     EISSN: 15476901     Source Type: Journal    
DOI: 10.3109/1547691X.2015.1058306     Document Type: Article

References (35)

1. Bendich, A. 1993. Physiological role of anti-oxidants in the immune system. J. Dairy Sci. 76:2789-2794.
2. Byun, H. O., Kim, H. Y., Lim, J. J., et al. 2008. Mitochondrial dysfunction by complex II inhibition delays overall cell cycle progression via reactive oxygen species production. J. Cell Biochem. 104: 1747-1759.
3. Choi, B. H., Ahn, I. S., Kim, Y. H., et al. 2006. Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte. Exp. Mol. Med. 38:599-605.
4. Devadas, S., Zaritskaya, L., Rhee, S. G., et al. 2002. Discrete generation of superoxide and hydrogen peroxide by T-cell receptor stimulation: Selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J. Exp. Med. 195:59-70.
5. Endo, T., Ogushi, F., and Sone, S. 1996. LPS-dependent COX-2 induction in human monocytes is down-regulated by IL-13, but not by IFNγ. J. Immunol. 156:2240-2246.
6. H2-type cytokines of the arachidonic acid metabolic pathways in human alveolar macrophages and monocytes. Am. J. Respir. Cell Mol. Biol. 19:300-307.
7. Fararjeh, M., Mohammad, M. K., Bustanji, Y., et al. 2008. Evaluation of immunosuppression induced by metronidazole in Balb/c mice and human peripheral blood lymphocytes. Intl. Immunopharmacol. 8: 341-350.
8. reg cells in vivo. Int. Immunopharmacol. 11:1802-1808.
9. Hasani-Ranjbar, S., Larijani, B., and Abdollahi, M. 2009. A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases. Inflamm. Allergy Drug Targets 8:2-10.
10. Ivanovska, N., and Philipov, S. 1996. Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions, and pure alkaloids. Int. J. Immunopharmacol. 18:553-561.
11. Ivanovska, N., Philipov, S., and Hristova, M. 1999. Influence of berberine on T-cell-mediated immunity. Immunopharmacol. Immunotoxicol. 21: 771-786.
12. Jeong, H.W., Hsu, K. C., Lee, J. W., et al. 2009. Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am. J. Physiol. 296:E955-964.
13. Kheir, M. M., Wang, Y., Hua, L., et al. 2010. Acute toxicity of berberine and its correlation with the blood concentration in mice. Food Chem. Toxicol. 48:1105-1110.
14. + T-cells during primary but not secondary viral infection. J. Virol. 78: 11246-11257.
15. Letasiova, S., Jantova, S., Muckova, M., and Theiszova, M. 2005. Antiproliferative activity of berberine in vitro and in vivo. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 149:461-463.
16. Li, Z., Geng, Y. N., Jiang, J. D., and Kong, W. J. 2014. Anti-oxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus. Evid.-Based Complement Alt. Med. 2014:289264.
17. Lin, W. C., and Lin, J. Y. 2011. Five bitter compounds display different anti-inflammatory effects through modulating cytokine secretion using mouse primary splenocytes in vitro. J. Agric. Food Chem. 59:184-92.
18. Los, M., Droge, W., Stricker, K., et al. 1995. Hydrogen peroxide as potent activator of T-lymphocyte functions. Eur. J. Immunol. 25:159-165.
19. Lou, T., Zhang, Z., Xi, Z., et al. 2011. Berberine inhibits inflammatory response and ameliorates insulin resistance in hepatocytes. Inflammation 34:659-667.
20. Luster, M. I., Dean, J. H., and Germolec, D. R. 2003. Consensus workshop on methods to evaluate developmental immunotoxicity. Environ. Health Perspect. 111:579-583.
21. Maemura, K., Zheng, Q., Wada, T., et al. 2005. Reactive oxygen species are essential mediators in antigen presentation by Kupffer cells. Immunol. Cell. Biol. 83:336-343.
22. Marinova, E. K., Nikolova, D. B., Popova, D. N., et al. 2000. Suppression of experimental autoimmune tubulointerstitial nephritis in BALB/c mice by berberine. Immunopharmacology 48:9-16.
23. Matsue, H., Edelbaum, D., Shalhevet, D., et al. 2003. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J. Immunol. 171:3010-3018.
24. H2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J. Immunol. 163:3771-3777.
25. Noori, S., Taghikhani, M., Hassan, Z. M., et al. 2010. Tehranolide molecule modulates the immune response, reduce regulatory T-cell and inhibits tumor growth in vivo. Mol. Immunol. 47:1579-1584.
26. Piganelli, J. D., Flores, S. C., Cruz, C., et al. 2002. A metalloporphyrin based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone. Diabetes 51: 347-355.
27. Rahnama, M., Mahmoudi, M., Zamani Taghizadeh Rabe, S., et al. 2014. Evaluation of anti-cancer and immunomodulatory effects of carnosol in a Balb/c WEHI-164 fibrosarcoma model. J. Immunotoxicol 12: 231-238.
28. Riahi, B., Rafatpanah, H., Mahmoudi, M., et al. 2010. Immunotoxicity of paraquat after subacute exposure to mice. Food Chem. Toxicol. 48: 1627-1631.
29. Riahi, B., Rafatpanah, H., Mahmoudi, M., et al. 2011. Evaluation of suppressive effects of paraquat on innate immunity in Balb/c mice. J. Immunotoxicol. 8:39-45.
30. Sarna, L. K., Wu, N., Hwang, S. Y., et al. 2010. Berberine inhibits NADPH oxidase-mediated superoxide anion production in macrophages. Can. Physiol. Pharmacol. 88:369-378.
31. 1 phase cell cycle progression. Cell Cycle 7:1782-1787.
32. Sena Laura, A., Li, S., Jairaman, A., et al. 2013. Mitochondria are required for antigen-specific T-cell activation through reactive oxygen species signaling. Immunity 38:225-236.
33. Smith-Garvin, J. E., Koretzky, G. A., and Jordan, M. S. 2009. T-Cell activation. Annu. Rev. Immunol. 27:591-619.
34. Tsang, C. M., Cheung, Y. C., Lui, V. W., et al. 2013. Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts. BMC Cancer 13:619.
35. Xu, L., Liu, Y., and He, X. 2005. Inhibitory effects of berberine on the activation and cell cycle progression of human peripheral lymphocytes. Cell. Mol. Immunol. 2:295-300.